Pharmaceutical industry – Page 4
-
OpinionTurning negative results into positives
Publishing unsuccessful experiments is more important than ever as we try to train machines in chemistry
-
BusinessContaminated cough syrups death toll passes 300 in four months
Deadly glycol contamination discovered in Uzbekistan, following cases in The Gambia and Indonesia
-
BusinessEncoding creativity in drug discovery
Machine learning can complement and reinforce human intuition and experience
-
OpinionThe psychology of our future with AI
It’s time to accept that digitalisation is changing laboratory work, and embrace the opportunity
-
BusinessMerck & Co identifies nitrosamine source in diabetes drugs
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning
-
BusinessSecond Alzheimer’s antibody approved in the US
Biogen–Eisai’s lecanemab can slow disease progression a little, but at significant cost and risk of side effects
-
OpinionSetting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
-
BusinessUK antibiotics supply chain stretched by surge in Strep A infections
Government enacts protocols to enable substitute treatments and recommends preventive prescriptions in severe cases
-
BusinessPharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
BusinessJudge dismisses ranitidine lawsuits over lack of evidence
Drug degrades to produce nitrosamines, but the judge ruled the link between this and plaintiffs’ cancers could not be proven
-
BusinessTheranos leaders to be imprisoned for blood testing fraud
Sunny Balwani and Elizabeth Holmes will both serve more than 10 years
-
BusinessUS government intervenes to avert rail strike
Congress enforces a contract deal to prevent a national rail shutdown that would effectively halt chemicals production
-
ArticleTime waits for no scientist: Five ways to enhance lab productivity and stay ahead of the competition in 2023
Manage your resources effectively to maximise your lab’s core activity: science
-
OpinionEmbracing oddities
When new chemistry looks like alchemy or witchcraft, it’s worth taking notice
-
ArticleThermal analysis in the development of long-acting injectable systems
Evaluating new polymers for slow-release drug delivery could deliver better treatment for patients
-
OpinionWhat to expect when your customer’s quality auditor visits
Checking a chemical plant is meeting standards
-
WebinarAnalytical impurity standards – minimise project risk & avoid common pitfalls
Learn how to save time and money by understanding what’s at stake when working with analytical impurity standards.
-
BusinessEurope gears up for streamlined patent system
Delayed Unified Patent Court set to begin operating in April
-
BusinessUK firms face critical lab space shortage
Growing chemistry companies hit a wall when it comes to expanding their labs
-
ArticleInspiring a new era of patient-centric medicines
Christian Jones discusses new formulations for drug delivery that put people first